Outsourcing Medical Affairs: MSL Teams, Med Info and Med Comms

When it makes sense to outsource medical affairs functions — field MSL teams, medical information contact centers, and medical communications — and how to evaluate the vendor segments.

Published July 21, 2026

Medical Affairs & Med Comms

Outsourcing medical affairs makes sense when a company needs capabilities faster than it can hire them, needs them for a defined window rather than permanently, or needs scale it cannot justify building — and it works best when the outsourced team executes against a medical strategy the company still owns internally. The three functions most commonly outsourced are field medical (contract MSL teams), medical information (med info contact centers and content), and medical communications (publications, congress activity, and scientific content). Each has a distinct vendor segment, cost structure, and set of trade-offs, and the biggest single mistake buyers make is treating them as one purchase.

The market behind this activity is growing quickly. A 2025 analysis by Towards Healthcare estimated the global medical affairs outsourcing market at $2.25 billion in 2024, projected to reach $8.07 billion by 2034 — a 13.64% compound annual growth rate — with medical writing and publishing the largest service segment in 2024 and MSL services expected to grow fastest over the forecast period.

Why companies outsource medical affairs

Four situations account for most outsourcing decisions:

Launch timing. A field medical team needs to be engaging scientific leaders 12 to 18 months before approval. Recruiting, hiring, and training an internal MSL team on that clock is difficult for a first launch; contract teams can deploy in a fraction of the time.
Uncertain or bounded need. Pre-launch programs that may not get approved, loss-of-exclusivity tail periods, and geographic expansions are poor cases for permanent headcount.
Scale economics. A small biotech cannot efficiently run a 24/7 medical information line for one product. Vendors spread that infrastructure across many clients.
Specialized capability. Publications planning, HEOR writing, congress logistics, and med info content localization are episodic, specialized workstreams that even large companies routinely contract out.

McKinsey’s widely cited vision for medical affairs argued that the function is becoming a third strategic pillar alongside R&D and commercial, driven by evidence generation and scientific engagement demands — a shift that raises both the workload and the bar for execution quality, and helps explain why outsourced capacity keeps growing even at companies with mature internal teams.

The three functions, and their vendor segments

Contract MSL and field medical teams

Contract field medical vendors recruit, employ, train, and manage MSLs who work under your medical strategy and, typically, your brand. Providers in this segment include diversified medical affairs organizations and dedicated field-team specialists such as Amplity Health, EVERSANA, Inizio Medical, and The Medical Affairs Company, among others.

The Medical Affairs Professional Society (MAPS) has published a balanced practitioner debate on outsourced field teams, and the trade-offs it surfaces match what buyers report: speed of deployment, flexible scaling, and established training infrastructure on one side; questions about scientific depth in narrow indications, team continuity, and cultural integration on the other. Key contract terms to negotiate: named-person continuity provisions, conversion rights (the option to hire contract MSLs into internal roles later), clear insight-reporting requirements into your CRM, and training standards tied to your therapeutic area rather than generic onboarding.

A common pattern is hybrid: an internal core of senior MSLs who own scientific-leader relationships in top-tier accounts, with a contract team providing geographic coverage or surge capacity around launch.

Medical information

Medical information outsourcing covers the contact center that fields unsolicited HCP and patient questions, the standard response documents behind it, and the intake-and-triage handoffs for adverse events and product quality complaints. Vendors in this space — including Cencora PharmaLex, EVERSANA, and ProPharma — sell what is fundamentally a regulated operations service, so evaluation looks more like a quality audit than a creative pitch.

What to scrutinize: response-time and quality SLAs, medical reviewer qualifications, pharmacovigilance handoff procedures with documented reconciliation, language and time-zone coverage, and the content-maintenance process for standard responses when labels change. Because med info touches safety reporting, compliance and PV teams must be in the evaluation from the first meeting, not at contracting.

Medical communications

Med comms is the most fragmented segment: publications planning and medical writing, congress symposia and booth science, advisory boards, scientific platforms, and internal scientific training. The vendor pool ranges from global networks to independent and specialist agencies — including, alphabetically, AMICULUM, Caudex, Costello Medical, Envision Pharma Group, OPEN Health, Oxford PharmaGenesis, and Prime Global. Larger platforms such as Lumanity and Red Nucleus combine med comms with adjacent consulting and training services.

Selection here is about scientific quality and team fit. Evaluate writing samples in your indication, ask who specifically will staff the account, and test the agency’s command of Good Publication Practice and ICMJE authorship standards. Med comms engagements fail on team churn more than on capability, so ask about turnover and put continuity language in the contract.

The adjacent technology layer

A growing set of technology vendors supports both internal and outsourced medical affairs teams: scientific-expert identification and engagement analytics from companies such as H1 and Within3, and AI-assisted medical content and insights platforms such as Indegene and Sorcero. These are usually bought separately from services, but contract terms should ensure any vendor-operated team works inside your systems — insights logged in tools you keep when the contract ends.

Comparing the segments at a glance

Function	Typical contract shape	Primary risk to manage	Compliance center of gravity
Contract MSL teams	FTE-based, 1–3 years	Team continuity and scientific depth	Scientific exchange boundaries, fair-market value
Medical information	Per-contact or hybrid, multi-year	Quality and PV handoff failures	Adverse event reporting, labeling accuracy
Medical communications	Project or retainer	Team churn, generic content	Good Publication Practice, authorship standards

What should stay in-house

Outsourcing execution works; outsourcing judgment does not. The medical strategy, the scientific narrative, launch-critical scientific-leader relationships, insight synthesis that feeds development decisions, and final medical review accountability should remain internal even in heavily outsourced models. A useful test for any proposed scope: if this vendor disappeared in ninety days, would we still own the strategy, the key relationships, and the data? If the answer is no, the scope is too broad.

It is also worth watching the vendor landscape itself. Pharma services — including medical communications — is consolidating, and PwC’s 2026 health industries M&A outlook notes that buyers are now evaluating people-heavy services businesses partly on how AI will change their delivery models and margins. For buyers, that means two practical questions in every evaluation: who owns this vendor and how stable is that ownership, and how does the vendor use AI in writing and med info workflows — with what human oversight and what contractual accountability for accuracy?

Practical recommendation

Start from a capability map, not a vendor list. Write down the medical affairs capabilities your next 24 months require — field engagement, med info coverage, evidence dissemination — and mark each as core (build), bounded (contract), or episodic (project-based). Run separate evaluations for each function you outsource, with function-specific scorecards: operational SLAs and PV controls for med info, scientific depth and continuity for MSL teams, writing quality and team stability for med comms. And whatever the mix, keep strategy, relationships, and data ownership inside the company — the vendors that will serve you best are the ones comfortable working within that boundary.